Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese

Diabetes Research and Clinical Practice

Volumn 56, Issue 2, 2002, Pages 147-152

  Daimon, Makoto ^a   Oizumi, Toshihide ^a   Saitoh, Tamotsu ^a   Kameda, Wataru ^a   Yamaguchi, Hiroshi ^a   Ohnuma, Hiroshi ^a   Igarashi, Masahiko ^a   Manaka, Hideo ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Association; Calpain l0; Cholesterol; Diabetes; Polymorphism

Indexed keywords

CALPAIN; CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CALPAIN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERCHOLESTEROLEMIA; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0036124605     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00372-2     Document Type: Article

References (4)

1. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2
2. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
3. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
4. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model